depend
cell
type
present
microenviron
may
promot
tumor
growth
invas
metastasi
howev
microenviron
may
also
promot
success
antitumor
immun
respons
retard
tumor
growth
even
lead
tumor
reject
exampl
patient
nonsmal
cell
lung
carcinoma
divid
two
group
base
histolog
appear
tertiari
lymphoid
structur
tl
adjac
tumor
lung
patient
tl
strikingli
better
overal
prognosi
longterm
surviv
without
earli
studi
show
densiti
cell
dendrit
cell
tumorassoci
tl
correl
better
clinic
outcom
followup
studi
issu
journal
show
size
densiti
bcell
follicl
size
number
germin
center
number
antibodysecret
plasma
cell
tumorassoci
tl
also
correl
better
clinic
outcom
importantli
b
cell
respond
tumorassoci
tl
appear
particip
antitumor
immun
respons
b
cell
cultur
tlscontain
biopsi
produc
tumor
antigenspecif
antibodi
thu
seem
function
link
develop
tumorassoci
tl
protect
respons
tumor
might
tl
promot
antitumor
immun
tl
lung
often
term
bronchusassoci
lymphoid
tissu
balt
typic
observ
pulmonari
infect
inflamm
tissu
structur
similar
convent
lymphoid
organ
consist
larg
bcell
follicl
surround
tcell
area
also
contain
dendrit
cell
balt
function
like
secondari
lymphoid
organ
independ
initi
local
band
tcell
respons
serv
reservoir
memori
b
cell
importantli
mice
balt
strikingli
resist
mice
without
balt
pulmonari
infect
varieti
infecti
agent
fact
mice
balt
easili
surviv
dose
influenza
corona
viru
associ
sever
acut
respiratori
syndrom
rapidli
kill
mice
lack
balt
one
way
balt
protect
infecti
diseas
respiratori
tract
acceler
immun
respons
exampl
celldepend
antibodi
respons
influenza
corona
viru
associ
sever
acut
respiratori
syndrom
gener
earlier
mice
balt
mice
without
balt
although
current
studi
show
balt
associ
antitumor
antibodi
respons
yet
clear
whether
abil
make
tumorspecif
antibodi
correl
protect
effect
longterm
followup
studi
ongo
even
whether
tumorspecif
b
cell
respons
import
immun
effector
mechan
lung
cancer
nevertheless
given
abil
balt
acceler
antibodi
respons
infecti
agent
seem
like
benefici
effect
balt
clinic
outcom
lung
cancer
due
stimul
antitumor
immun
type
unfortun
correl
balt
format
better
clinic
outcom
provid
much
inform
way
mechan
exampl
one
possibl
patient
preexist
balt
lung
prior
onset
lung
cancer
although
format
balt
often
initi
pulmonari
infect
inflamm
balt
form
respond
unrel
infect
antigen
thu
balt
format
may
trigger
prior
infect
fortuit
promot
antitumor
immun
respons
make
immun
system
sensit
tumor
antigen
acceler
amplifi
nascent
antitumor
immun
respons
even
alter
accumul
placement
cell
lung
note
immun
respons
mycobacterium
tuberculosi
given
current
data
seem
b
cell
like
play
import
role
antitumor
immun
perhap
captur
present
tumor
antigen
tdr
support
nih
grant
cell
gener
tumor
antigenspecif
antibodi
target
tumor
antigen
dendrit
cell
express
receptor
antibodi
constant
region
figur
convers
develop
balt
may
trigger
lung
tumor
exampl
lung
tumor
may
immunogen
other
immunogen
tumor
may
promot
balt
format
consequ
antitumor
immun
includ
activ
b
cell
thu
balt
may
either
caus
effect
antitumor
immun
respons
futur
studi
need
distinguish
possibl
could
understand
bcell
immunolog
help
us
clinic
current
dogma
suggest
tumor
surveil
perform
cell
specif
cell
howev
success
immun
respons
control
complex
interplay
primari
tumor
cell
b
cell
limit
data
concern
bcell
immunolog
lung
cancer
data
current
report
allow
us
pose
varieti
question
answer
yield
clinic
use
answer
exampl
could
tl
predict
efficaci
therapi
current
studi
tl
densiti
follicular
b
cell
matur
dendrit
cell
predict
better
outcom
patient
earli
advanc
diseas
therefor
tl
may
surrog
treatment
respons
second
could
tl
guid
therapi
stratif
patient
optim
outcom
current
studi
suggest
assess
tl
addit
typic
clinic
paramet
may
stratifi
patient
highor
lowrisk
popul
predict
outcom
perhap
identifi
individu
high
risk
recurr
might
benefit
adjuv
therapi
individu
need
therapi
next
could
tl
lead
us
new
therapeut
paradigm
anim
model
breast
cancer
uniqu
subset
transform
growth
factorbproduc
regulatori
b
cell
trigger
differenti
metastasispromot
regulatori
cell
inactiv
antitumor
natur
killer
cell
effector
cell
therefor
transform
growth
factorbproduc
regulatori
b
cell
breg
promot
metastasi
tumor
progressiona
role
b
cell
appar
opposit
identifi
current
studi
thu
novel
therapeut
approach
suppress
breg
function
promot
therapeut
activ
b
cell
find
may
also
impact
drug
immunotherapi
develop
lung
cancer
prognost
valu
tl
confirm
futur
prospect
clinic
trial
may
need
stratifi
outcom
base
tl
final
chang
tlsneg
tumor
tlsposit
tumor
tlr
ligand
promot
balt
format
mice
may
use
therapeut
alter
immunosuppress
microenviron
induc
cancer
cell
lead
bcell
accumul
activ
adjac
tumor
lung
summari
current
studi
provid
intrigu
insight
b
cellmedi
antitumor
immunolog
lung
cancer
suggest
novel
therapeut
approach
key
next
step
field
figur
role
bronchusassoci
lymphoid
tissu
balt
immun
lung
cancer
b
cell
balt
may
facilit
antitumor
immun
respons
directli
acquir
tumor
antigen
via
tumor
antigenspecif
bcr
present
process
tumor
antigen
cell
b
cell
may
also
produc
tumor
antigenspecif
antibodi
bind
tumor
antigen
gener
immun
complex
taken
via
fcr
dendrit
cell
present
process
tumor
antigen
cell
activ
cell
may
kill
tumor
cell
directli
may
recruit
inflammatori
cell
either
kill
tumor
cell
impair
growth
tumor
antigenspecif
antibodi
may
also
directli
target
tumor
cell
destruct
via
complementmedi
natur
killer
cellmedi
destruct
presenc
balt
adjac
tumor
site
facilit
antigen
captur
well
interact
variou
immun
cell
lead
immun
activ
overcom
tumormedi
immun
suppress
bcr
bcell
receptor
fcr
receptor
antibodi
constant
region
nsclc
nonsmal
cell
lung
carcinoma
